BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31347390)

  • 1. Open science: The open clinical trials data journey.
    Rockhold F; Bromley C; Wagner EK; Buyse M
    Clin Trials; 2019 Oct; 16(5):539-546. PubMed ID: 31347390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource implications of preparing individual participant data from a clinical trial to share with external researchers.
    Tudur Smith C; Nevitt S; Appelbe D; Appleton R; Dixon P; Harrison J; Marson A; Williamson P; Tremain E
    Trials; 2017 Jul; 18(1):319. PubMed ID: 28712359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach.
    Hughes S; Wells K; McSorley P; Freeman A
    Pharm Stat; 2014; 13(3):179-83. PubMed ID: 24668938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers.
    Sudlow R; Branson J; Friede T; Morgan D; Whately-Smith C
    BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):73. PubMed ID: 27410386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transparency and objectivity in governance of clinical trials data sharing: Current practices and approaches.
    Shabani M; Obasa M
    Clin Trials; 2019 Oct; 16(5):547-551. PubMed ID: 31347399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sharing data from clinical trials: the rationale for a controlled access approach.
    Sydes MR; Johnson AL; Meredith SK; Rauchenberger M; South A; Parmar MK
    Trials; 2015 Mar; 16():104. PubMed ID: 25872927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of transparency indicators across the biomedical literature: How open is open?
    Serghiou S; Contopoulos-Ioannidis DG; Boyack KW; Riedel N; Wallach JD; Ioannidis JPA
    PLoS Biol; 2021 Mar; 19(3):e3001107. PubMed ID: 33647013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting patient privacy when sharing patient-level data from clinical trials.
    Tucker K; Branson J; Dilleen M; Hollis S; Loughlin P; Nixon MJ; Williams Z
    BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):77. PubMed ID: 27410040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on clinical trial data transparency and disclosure.
    Alemayehu D; Anziano RJ; Levenstein M
    Contemp Clin Trials; 2014 Sep; 39(1):28-33. PubMed ID: 25017444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of available studies and dissemination of research using major clinical data sharing platforms.
    Vazquez E; Gouraud H; Naudet F; Gross CP; Krumholz HM; Ross JS; Wallach JD
    Clin Trials; 2021 Dec; 18(6):657-666. PubMed ID: 34407656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumps and bridges on the road to responsible sharing of clinical trial data.
    Berlin JA; Morris S; Rockhold F; Askie L; Ghersi D; Waldstreicher J
    Clin Trials; 2014 Feb; 11(1):7-12. PubMed ID: 24408901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharing and reuse of individual participant data from clinical trials: principles and recommendations.
    Ohmann C; Banzi R; Canham S; Battaglia S; Matei M; Ariyo C; Becnel L; Bierer B; Bowers S; Clivio L; Dias M; Druml C; Faure H; Fenner M; Galvez J; Ghersi D; Gluud C; Groves T; Houston P; Karam G; Kalra D; Knowles RL; Krleža-Jerić K; Kubiak C; Kuchinke W; Kush R; Lukkarinen A; Marques PS; Newbigging A; O'Callaghan J; Ravaud P; Schlünder I; Shanahan D; Sitter H; Spalding D; Tudur-Smith C; van Reusel P; van Veen EB; Visser GR; Wilson J; Demotes-Mainard J
    BMJ Open; 2017 Dec; 7(12):e018647. PubMed ID: 29247106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should individual participant data (IPD) from publicly funded clinical trials be shared?
    Tudur Smith C; Hopkins C; Sydes MR; Woolfall K; Clarke M; Murray G; Williamson P
    BMC Med; 2015 Dec; 13():298. PubMed ID: 26675031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To share or not to share? Expected pros and cons of data sharing in radiological research.
    Sardanelli F; Alì M; Hunink MG; Houssami N; Sconfienza LM; Di Leo G
    Eur Radiol; 2018 Jun; 28(6):2328-2335. PubMed ID: 29349697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncommercial US Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
    Whitlock EP; Dunham KM; DiGioia K; Lazowick E; Gleason TC; Atkins D
    JAMA Netw Open; 2019 Jan; 2(1):e187498. PubMed ID: 30681715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical research data sharing: what an open science world means for researchers involved in evidence synthesis.
    Ross JS
    Syst Rev; 2016 Sep; 5(1):159. PubMed ID: 27649796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns.
    Hopkins C; Sydes M; Murray G; Woolfall K; Clarke M; Williamson P; Tudur Smith C
    J Clin Epidemiol; 2016 Feb; 70():17-25. PubMed ID: 26169841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting the Focus Back on the Patient: How Privacy Concerns Affect Personal Health Information Sharing Intentions.
    Abdelhamid M; Gaia J; Sanders GL
    J Med Internet Res; 2017 Sep; 19(9):e169. PubMed ID: 28903895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic dataset primer for the biobehavioural sciences to promote reproducibility and hypothesis generation.
    Quintana DS
    Elife; 2020 Mar; 9():. PubMed ID: 32159513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.